Home  /  Resource Library  /  A single-center retrospective study suggests a potential benefit of BTK inhibitor-based therapy in patients with histologic transformation of Waldenstrom macroglobulinemia

A single-center retrospective study suggests a potential benefit of BTK inhibitor-based therapy in patients with histologic transformation of Waldenstrom macroglobulinemia

Study investigated BTK inhibitors for treatment of transformed Waldenstrom macroglobulinemia.